TELA Bio (TELA) Income from Continuing Operations (2018 - 2026)
TELA Bio (TELA) posted quarterly Income from Continuing Operations of 12273000.0 for Q1 2026, down 8.96% year-over-year from 13480553.1 in Q1 2025, and down 37.95% quarter-over-quarter from 8897000.0 in Q4 2025.
TELA Bio (TELA) Income from Continuing Operations (2018 - 2026) Analysis & Trends
TELA Bio's Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 12273000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 8.96% year-over-year to 12273000.0; the TTM figure through Mar 2026 stood at 39696000.0 (down 695.83% YoY), while the FY2025 annual figure was 38687000.0, down 550.27% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 12273000.0, down from 8897000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 29248000.0 in Q4 2024, with the low at 14047000.0 in Q4 2023.
- The 5-year median for Income from Continuing Operations is 11171000.0 (2022), against an average of 8409647.06.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations jumped 308.22% in 2024, then plunged 130.42% in 2025.
- TELA Bio's Income from Continuing Operations stood at 9162000.0 in 2022, then sank by 53.32% to 14047000.0 in 2023, then surged by 308.22% to 29248000.0 in 2024, then slumped by 130.42% to 8897000.0 in 2025, then tumbled by 37.95% to 12273000.0 in 2026.
- Business Quant data shows TELA's Income from Continuing Operations at 12273000.0 in Q1 2026, 8897000.0 in Q4 2025, and 8603000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | TELA Bio | 36.34 Mn | 5.92 Mn | 13.94 Mn | -11.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.26 Mn |
| Mar 31, 2026 | -12.27 Mn |
| Dec 31, 2025 | -8.90 Mn |
| Sep 30, 2025 | -8.60 Mn |
| Jun 30, 2025 | -9.92 Mn |
| Mar 31, 2025 | -11.26 Mn |
| Dec 31, 2024 | 29.25 Mn |
| Sep 30, 2024 | -10.37 Mn |
| Jun 30, 2024 | -12.60 Mn |
| Mar 31, 2024 | -5.66 Mn |
| Dec 31, 2023 | -14.05 Mn |
| Sep 30, 2023 | -11.52 Mn |
| Jun 30, 2023 | -12.36 Mn |
| Mar 31, 2023 | -12.50 Mn |
| Dec 31, 2022 | -9.16 Mn |
| Sep 30, 2022 | -10.69 Mn |
| Jun 30, 2022 | -11.17 Mn |
| Mar 31, 2022 | -11.18 Mn |
| Dec 31, 2021 | -7.89 Mn |
| Sep 30, 2021 | -11.32 Mn |